Status: current, Defined. Date: 28-Feb 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4672131000168110 | severe acute respiratory syndrome coronavirus-2 recombinant spike protein (NVX-CoV2373) antigen (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4672141000168118 | COVID-19 (NVX-CoV2373) vaccine | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4672251000168111 | SARS-CoV-2 rS (severe acute respiratory syndrome coronavirus-2 recombinant spike protein) (NVX-CoV2373) antigen | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4672261000168113 | SARS-CoV-2 rS (NVX-CoV2373) antigen | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| COVID-19 (NVX-CoV2373) vaccine | Is a | medicinal product | true | Inferred relationship | Some | ||
| COVID-19 (NVX-CoV2373) vaccine | has intended active ingredient | SARS-CoV-2 rS (NVX-CoV2373) antigen | true | Inferred relationship | Some | 1052506438 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| COVID-19 (NVX-CoV2373) vaccine injection, 5 mL vial | Is a | True | COVID-19 (NVX-CoV2373) vaccine | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR